Witnessing the stock’s movement on the chart, on Thursday, Pacific Biosciences of California Inc (NASDAQ: PACB) had a quiet start as it plunged -6.31% to
On Monday, Pacific Biosciences of California Inc (NASDAQ: PACB) was 6.96% up from the session before settling in for the closing price of $2.30. A
Pacific Biosciences of California Inc (NASDAQ: PACB) open the trading on Thursday, with a bit cautious approach as it glided -7.55% to $2.45, before settling
Pacific Biosciences of California Inc (NASDAQ: PACB) kicked off on Monday, up 2.87% from the previous trading day, before settling in for the closing price
Pacific Biosciences of California Inc (NASDAQ: PACB) established initial surge of 0.46% at $2.17, before settling in for the price of $2.16 at the close.
On Monday, Pacific Biosciences of California Inc (NASDAQ: PACB) opened higher 3.95% from the last session, before settling in for the closing price of $1.77.
Pacific Biosciences of California Inc (NASDAQ: PACB) open the trading on Thursday, with a bit cautious approach as it glided -1.71% to $1.72, before settling
A new trading day began on Monday, with Pacific Biosciences of California Inc (NASDAQ: PACB) stock price down -7.07% from the previous day of trading,
Pacific Biosciences of California Inc (NASDAQ: PACB) open the trading on Thursday, with a bit cautious approach as it glided -7.77% to $1.90, before settling
Pacific Biosciences of California Inc (NASDAQ: PACB) on Monday, plunged -2.86% from the previous trading day, before settling in for the closing price of $1.75.
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
